Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 4Recruiting 3Active not recruiting 3Unknown 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 1Papillomavirus Infections 1

Interventions

Cyclophosphamide 1492Cisplatin 1413Paclitaxel 1316Radiotherapy 1261Carboplatin 1249Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700Etoposide 678pembrolizumab 677Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Human Papillomavirus DNA Tests × Clear all
NCT03757299 2025-01-15

PCCCP

University Hospital, Geneva

Phase NA Completed
4,473 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02067468 2019-09-19

ASCUS-COL

Universidad de Antioquia

Phase NA Completed
2,661 enrolled 18 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03466710 2018-05-02

Post Colposcopy Management of ASC-US and LSIL Pap Tests

University of Calgary

Phase NA Completed
133 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02811367 2016-10-17

The HPV Self-test as a Test of Cure in Madagascar

University Hospital, Geneva

Phase NA Completed
117 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡